RHINEDRINE, solution as a nasal spray bottle, 13 ml
Active ingredients: Benzododecinium bromide
Commercialized according to BDPM
Solution for sprayingbottle, 13 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RHINEDRINE, solution pour pulvérisation nasale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) polyéthylène de 13 ml avec tube plongeur polyéthylène
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Jun 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69290698CIP73413168CIP133400934131684Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE DE BENZODODÉCINIUMsolution | 0,0503 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.